FDA.reportPublic FDA data

POLYSORBATE 65

Substance profile for UNII 14BGY2Y3MJ, enriched with FDA NDC listings, DailyMed labels, legacy aliases, and open chemistry identifiers.

Substance Identity#

UNII
14BGY2Y3MJ
Preferred term
POLYSORBATE 65
Registry number
9005-71-4
Ingredient type
INGREDIENT SUBSTANCE
Molecular formula
Polymer substance not supported

Chemical And Database Identifiers#

RxCUI
1426405
PubChem
0
INN ID
0

Open Chemistry Sources#

Source, Identifier, Link table
SourceIdentifierLink
RxNorm1426405https://mor.nlm.nih.gov/RxNav/search?searchBy=RXCUI&searchTerm=1426405
FDA Substance Registration System14BGY2Y3MJhttps://precision.fda.gov/uniisearch/srs/unii/14BGY2Y3MJ

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
POLYSORBATE 65INACTIVE INGREDIENT14BGY2Y3MJThese highlights do not include all the information needed to use atorvastatin calcium tablets safely and effectively. See full prescribing information for atorvastatin calcium tablets. Atorvastatin calcium tablets for oral administration Initial U.S. Approval: 19961
POLYSORBATE 65INACTIVE INGREDIENT14BGY2Y3MJREVITALIZING MOISTURIZING SUNSCREEN CREAM - SPF-201
POLYSORBATE 65INACTIVE INGREDIENT14BGY2Y3MJThese highlights do not include all the information needed to use atorvastatin calcium tablets safely and effectively. See full prescribing information for atorvastatin calcium tablets. Atorvastatin calcium tablets for oral administration Initial U.S. Approval: 19964
POLYSORBATE 65INACTIVE INGREDIENT14BGY2Y3MJThese highlights do not include all the information needed to use atorvastatin calcium safely and effectively. See full prescribing information for atorvastatin calcium tablets. Atorvastatin calcium tablets for oral administration Initial U.S. Approval: 19962
POLYSORBATE 65INACTIVE INGREDIENT14BGY2Y3MJThese highlights do not include all the information needed to use atorvastatin calcium safely and effectively. See full prescribing information for atorvastatin calcium tablets. Atorvastatin calcium tablets for oral administration Initial U.S. Approval: 19961
POLYSORBATE 65INACTIVE INGREDIENT14BGY2Y3MJATORVASTATIN CALCIUM TABLET, FILM COATED [BRYANT RANCH PREPACK]1000
POLYSORBATE 65INACTIVE INGREDIENT14BGY2Y3MJATORVASTATIN CALCIUM TABLET, FILM COATED [RANBAXY PHARMACEUTICALS INC.]7
POLYSORBATE 65INACTIVE INGREDIENT14BGY2Y3MJATORVASTATIN CALCIUM TABLET, FILM COATED [RANBAXY PHARMACEUTICALS INC.]6
POLYSORBATE 65INACTIVE INGREDIENT14BGY2Y3MJATORVASTATIN CALCIUM TABLET, FILM COATED [PD-RX PHARMACEUTICALS, INC.]5
POLYSORBATE 65INACTIVE INGREDIENT14BGY2Y3MJFENOFIBRATE CAPSULE [RANBAXY PHARMACEUTICALS INC.]4
POLYSORBATE 65INACTIVE INGREDIENT14BGY2Y3MJSHOPRITE INFANTS SIMETHICONE (SIMETHICONE) EMULSION [WAKEFERN FOOD CORPORATION]1
POLYSORBATE 65INACTIVE INGREDIENT14BGY2Y3MJTRILIPIDERM BROAD SPECTRUM SPF 30 (BUTYL METHOXYDIBENZOYLMETHANE, ETHYLHEXYL METHOXYCINNAMATE, HOMOSALATE, OCTOCRYLENE) CREAM [TRILIPID RESEARCH INSTITUTE, LLC]1